New Vaccinia Virus Shows Potential For Treating Triple-Negative Breast Cancer

[News]

Researchers from Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City have shown that a new vaccinia virus, acting as both an oncolytic and anti-angiogenic agent, can enter and kill triple-negative breast cancer (TNBC) cells...

More... (http://www.medicalnewstoday.com/releases/250956.php)